CIDARA THERAPEUTICS INC (CDTX)
US1717572069 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -22.93M | -29.80M | -42.47M | -72.11M | -41.09M | |||
| Depreciation Amortization | 118.00K | 140.00K | 190.00K | 290.00K | 330.00K | |||
| Change In Working Capital | -3.92M | -3.43M | 14.44M | 13.36M | 7.49M | |||
| Interest Paid | 0.00 | 40.00K | 230.00K | 450.00K | 620.00K | |||
| Other non cash items | 4.30M | 4.62M | 2.61M | 4.05M | 4.75M | |||
| OPERATING CASH FLOW | -22.43M | -28.47M | -25.23M | -54.41M | -28.53M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -505.00K | -120.00K | -40.00K | -190.00K | -40.00K | |||
| Other Investing Activity | N/A | N/A | N/A | 0.00 | 0.00 | |||
| INVESTING CASH FLOW | -505.00K | -120.00K | -40.00K | -190.00K | -40.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 0.00 | -2.59M | -4.44M | -2.96M | N/A | |||
| Stock Issued/Repurchased | 25.98M | 1.64M | 49.04M | 40.24M | 14.30M | |||
| Other Financing Activity | N/A | N/A | 0.00 | 0.00 | -30.00K | |||
| FINANCING CASH FLOW | 25.98M | -950.00K | 44.60M | 37.28M | 14.27M | |||
| CHANGE IN CASH | 3.05M | -29.54M | 19.33M | -17.32M | -14.30M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -22.43M | -28.47M | -25.23M | -54.41M | -28.53M | |||
| Capital Expenditure | -505.00K | -120.00K | -40.00K | -190.00K | -40.00K | |||
| FREE CASH FLOW | -22.94M | -28.59M | -25.27M | -54.60M | -28.57M | |||
All data in USD